Persistent high-risk HPV infection of the cervix
Conditions
Interventions
Treatment Group:Rinse the vagina with QingDu Solution
Control Group:Rinse the vagina with placebo
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
21 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) Cervical HR-HPV infection = 6 months, colposcopic pathological grade = cervical low-grade squamous intraepithelial lesions (LSIL); 2) Female aged 21-65 years old, premenopausal requiring regular menstruation and intermenstrual period of more than 21 days; 3) No participation in other clinical drug trials within the past 1 month, and no medications with therapeutic effects similar to the test drugs; 4) No fertility requirements in the next six months; 5) No antibiotics in the past 1 month; 6) Willing to cooperate with treatment follow-up and sign informed consent;
Exclusion criteria
Exclusion criteria: 1) Acute genital infections including candidal vaginitis, trichomonas vaginitis, genital chlamydia infection, and acute pelvic inflammatory diseases; 2) Vaginal cleanliness IV degree; 3) Pregnant and lactating women; 4) Patients with systemic chronic wasting diseases, severe cardiovascular diseases, liver and kidney diseases, and hematopoietic system diseases; 5) Patients with mental diseases; 6) Patients with a history of immune system diseases and under immunosuppressive therapy; 7)Patients had history of drug allergy or allergic reaction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| High Risk Human Papillomavirus overcast rate ;Reversal rate of cervical low-grade squamous intra-epithelial lesion (LSIL); | — |
Countries
China
Contacts
Public ContactJing Xiao
Outcome results
None listed